Shareholder Communications

For the attention of warrant-holders : The press release of 31 May 2022 does NOT constitute the announcement of the top-line results in respect of the LUCIDITY trial or Study 039, which results will be announced at a later date.

30th August 2021 Correspondence for Shareholders of TauRx Pharmaceuticals Ltd. Not Resident in Singapore letter

8th October 2021 Correspondence for Shareholders of TauRx Pharmaceuticals Ltd. Not Resident in Singapore letter

Back to About